NCT04116983 - DERM NMSC Validation Study | Biotech Hunter

Enrollment

572

Participants

Timeline

Start Date

June 26, 2020

Primary Completion Date

February 28, 2022

Study Completion Date

March 16, 2022

Conditions

Non-melanoma Skin Cancer

Interventions

DEVICE

Deep Ensemble for the Recognition of Malignancy (DERM)

An AI-based diagnosis support tool

Trial Locations (3)

Royal Free London NHS Foundation Trust, London

Royal Victoria Infirmary, Newcastle upon Tyne

Poole General Hospital, Poole